Structure and interactions of the human programmed cell death 1 receptor

Journal of Biological Chemistry

Volumn 288, Issue 17, 2013, Pages 11771-11785

  Cheng, Xiaoxiao ^a,b   Veverka, Vaclav ^c,d   Radhakrishnan, Anand ^e   Waters, Lorna C ^c   Muskett, Frederick W ^c   Morgan, Sara H ^a,b   Huo, Jiandong ^a,b   Yu, Chao ^a,b   Evans, Edward J ^a,b   Leslie, Alasdair J ^a   Griffiths, Meryn ^f   Stubberfield, Colin ^f   Griffin, Robert ^f   Henry, Alistair J ^f   Jansson, Andreas ^g   Ladbury, John E ^g   Ikemizu, Shinji ^h   Carr, Mark D ^c   Davis, Simon J ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^e UNIVERSITY OF TEXAS   (United States)

^f UCB PHARMA   (Belgium)

^g UNIVERSITY OF SKÖVDE   (Sweden)

^h KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTING CELLS; DISSOCIATION RATES; EXTRACELLULAR REGION; ISOTHERMAL TITRATION CALORIMETRY; MATHEMATICAL SIMULATIONS; NUCLEAR MAGNETIC RESONANCE(NMR); PROGRAMMED CELL DEATHS; THERAPEUTIC TARGETS;

CELL DEATH; COMPLEXATION; DIGITAL STORAGE; DISSOCIATION;

LIGANDS;

B7 ANTIGEN; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; PROGRAMMED DEATH 1 RECEPTOR;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENTHALPY; FEMALE; HUMAN; HUMAN CELL; ISOTHERMAL TITRATION CALORIMETRY; LIGAND BINDING; MOLECULAR MODEL; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; SURFACE PLASMON RESONANCE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD274; ANTIGENS, CD80; CELL COMMUNICATION; HUMANS; MICE; MODELS, IMMUNOLOGICAL; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN; PROGRAMMED CELL DEATH 1 RECEPTOR; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PLASMON RESONANCE; T-LYMPHOCYTES;

EID: 84876924130     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.448126     Document Type: Article

References (65)

1. Nishimura, H., Nose, M., Hiai, H., Minato, N., and Honjo, T. (1999) Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11, 141-151
2. Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., and Honjo, T. (2001) Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291, 319-322
3. Ferreiros-Vidal, I., Gomez-Reino, J. J., Barros, F., Carracedo, A., Carreira, P., Gonzalez-Escribano, F., Liz, M., Martin, J., Ordi, J., Vicario, J. L., and Gonzalez, A. (2004) Association of PDCD1 with susceptibility to systemic lupus erythematosus. Evidence of population-specific effects. Arthritis Rheum. 50, 2590-2597
4. James, E. S., Harney, S., Wordsworth, B. P., Cookson, W. O., Davis, S. J., and Moffatt, M. F. (2005) PDCD1. A tissue-specific susceptibility locus for inherited inflammatory disorders. Genes Immun. 6, 430-437
5. Kong, E. K., Prokunina-Olsson, L., Wong, W. H., Lau, C. S., Chan, T. M., Alarcón-Riquelme, M., and Lau, Y. L. (2005) A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum. 52, 1058-1062
6. Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., and Ahmed, R. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682-687
7. + T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. Blood 110, 928-936
8. Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., Mncube, Z., Duraiswamy, J., Zhu, B., Eichbaum, Q., Altfeld, M., Wherry, E. J., Coovadia, H. M., Goulder, P. J., Klenerman, P., Ahmed, R., Freeman, G. J., and Walker, B. D. (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350-354
9. Radziewicz, H., Ibegbu, C. C., Fernandez, M. L., Workowski, K. A., Obideen, K., Wehbi, M., Hanson, H. L., Steinberg, J. P., Masopust, D., Wherry, E. J., Altman, J. D., Rouse, B. T., Freeman, G. J., Ahmed, R., and Grakoui, A. (2007) Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J. Virol. 81, 2545-2553
10. Urbani, S., Amadei, B., Tola, D., Massari, M., Schivazappa, S., Missale, G., and Ferrari, C. (2006) PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J. Virol. 80, 11398-11403
11. + T cells during acute HCV infection, irrespective of clinical outcome. J. Virol. 82, 3154-3160
12. Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., and Sharpe, A. H. (2009) PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 206, 3015-3029
13. Topalian, S. L., Drake, C. G., and Pardoll, D. M. (2012) Targeting the PD-1/B7-H1 (PD-L1) pathway to activate anti-tumor immunity. Curr. Opin. Immunol. 24, 207-212
14. Yokosuka, T., Takamatsu, M., Kobayashi-Imanishi, W., Hashimoto-Tane, A., Azuma, M., and Saito, T. (2012) Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J. Exp. Med. 209, 1201-1217
15. Keir, M. E., Butte, M. J., Freeman, G. J., and Sharpe, A. H. (2008) PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26, 677-704
16. Dong, H., Zhu, G., Tamada, K., and Chen, L. (1999) B7-H1, a third member of the B7 family, costimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5, 1365-1369
17. Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., Horton, H. F., Fouser, L., Carter, L., Ling, V., Bowman, M. R., Carreno, B. M., Collins, M., Wood, C. R., and Honjo, T. (2000) Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027-1034
18. Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., Greenfield, E. A., Bourque, K., Boussiotis, V. A., Carter, L. L., Carreno, B. M., Malenkovich, N., Nishimura, H., Okazaki, T., Honjo, T., Sharpe, A. H., and Freeman, G. J. (2001) PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2, 261-268
19. Tseng, S. Y., Otsuji, M., Gorski, K., Huang, X., Slansky, J. E., Pai, S. I., Shalabi, A., Shin, T., Pardoll, D. M., and Tsuchiya, H. (2001) B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193, 839-846
20. Riley, J. L. (2009) PD-1 signalling in primary T cells. Immunol. Rev. 229, 114-125
21. Yu, C., Sonnen, A. F., George, R., Dessailly, B. H., Stagg, L. J., Evans, E. J., Orengo, C. A., Stuart, D. I., Ladbury, J. E., Ikemizu, S., Gilbert, R. J., and Davis, S. J. (2011) Rigid-body ligand recognition drives cytotoxic T-lymphocyte antigen 4 (CTLA-4) receptor triggering. J. Biol. Chem. 286, 6685-6696
22. Butte, M. J., Keir, M. E., Phamduy, T. B., Sharpe, A. H., and Freeman, G. J. (2007) Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 27, 111-122
23. Butte, M. J., Peña-Cruz, V., Kim, M. J., Freeman, G. J., and Sharpe, A. H. (2008) Interaction of human PD-L1 and B7-1. Mol. Immunol. 45, 3567-3572
24. Lin, D. Y., Tanaka, Y., Iwasaki, M., Gittis, A. G., Su, H. P., Mikami, B., Okazaki, T., Honjo, T., Minato, N., and Garboczi, D. N. (2008) The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors. Proc. Natl. Acad. Sci. U. S. A. 105, 3011-3016
25. Lázár-Molnár, E., Yan, Q., Cao, E., Ramagopal, U., Nathenson, S. G., and Almo, S. C. (2008) Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2. Proc. Natl. Acad. Sci. U. S. A. 105, 10483-10488
26. Springer, T. A. (1991) Cell adhesion. A birth certificate for CD2. Nature 353, 704-705
27. Davis, S. J., Ward, H. A., Puklavec, M. J., Willis, A. C., Williams, A. F., and Barclay, A. N. (1990) High level expression in Chinese hamster ovary cells of soluble forms of CD4 T lymphocyte glycoprotein including glycosylation variants. J. Biol. Chem. 265, 10410-10418
28. Collins, A. V., Brodie, D. W., Gilbert, R. J., Iaboni, A., Manso-Sancho, R., Walse, B., Stuart, D. I., van der Merwe, P. A., and Davis, S. J. (2002) The interaction properties of costimulatory molecules revisited. Immunity 17, 201-210
29. van der Merwe, P. A., Bodian, D. L., Daenke, S., Linsley, P., and Davis, S. J. (1997) CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J. Exp. Med. 185, 393-403
30. Veverka, V., Lennie, G., Crabbe, T., Bird, I., Taylor, R. J., and Carr, M. D. (2006) NMR assignment of the mTOR domain responsible for rapamycin binding. J. Biomol. NMR 36, 3
31. Waters, L. C., Böhm, M., Veverka, V., Muskett, F. W., Frenkiel, T. A., Kelly, G. P., Prescott, A., Dosanjh, N. S., Klempnauer, K. H., and Carr, M. D. (2006) NMR assignment and secondary structure determination of the C-terminal MA-3 domain of the tumour suppressor protein Pdcd4. J. Biomol. NMR 36, 18
32. Renshaw, P. S., Veverka, V., Kelly, G., Frenkiel, T. A., Williamson, R. A., Gordon, S. V., Hewinson, R. G., and Carr, M. D. (2004) Sequence-specific assignment and secondary structure determination of the 195-residue complex formed by the Mycobacterium tuberculosis proteins CFP-10 and ESAT-6. J. Biomol. NMR 30, 225-226
33. Wilkinson, I. C., Hall, C. J., Veverka, V., Shi, J. Y., Muskett, F. W., Stephens, P. E., Taylor, R. J., Henry, A. J., and Carr, M. D. (2009) High resolution NMR-based model for the structure of a scFv-IL-1β complex. Potential for NMR as a key tool in therapeutic antibody design and development. J. Biol. Chem. 284, 31928-31935
34. Herrmann, T., Güntert, P., and Wüthrich, K. (2002) Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J. Mol. Biol. 319, 209-227
35. Veverka, V., Crabbe, T., Bird, I., Lennie, G., Muskett, F. W., Taylor, R. J., and Carr, M. D. (2008) Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor. Compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR. Oncogene 27, 585-595
36. +. A hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J. Biomol. NMR 44, 213-223
37. Güntert, P., and Wüthrich, K. (1991) Improved efficiency of protein structure calculations from NMR data using the program DIANA with redundant dihedral angle constraints. J. Biomol. NMR 1, 447-456
38. Case, D. A., Cheatham, T. E., 3rd, Darden, T., Gohlke, H., Luo, R., Merz, K. M., Jr., Onufriev, A., Simmerling, C., Wang, B., and Woods, R. J. (2005) The Amber biomolecular simulation programs. J. Comput. Chem. 26, 1668-1688
39. Tsui, V., and Case, D. A. (2000) Molecular dynamics simulations of nucleic acids using a generalized Born solvation model. J. Am. Chem. Soc. 122, 2489-2498
40. Koradi, R., Billeter, M., and Wüthrich, K. (1996) MOLMOL. A program for display and analysis of macromolecular structures. J. Mol. Graph. 14, 51-55, 29-32
41. Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., 3rd, Snoeyink, J., Richardson, J. S., and Richardson, D. C. (2007) MolProbity. All-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 35, W375-W383
42. DeLano, W. L. (2010) The PyMOL Molecular Graphics System, version 1.3r1, Schrodinger, LLC, New York
43. + binding site on the MurB enzyme by NMR. Nat. Struct. Mol. Biol. 3, 995-997
44. Muskett, F. W., Frenkiel, T. A., Feeney, J., Freedman, R. B., Carr, M. D., and Williamson, R. A. (1998) High resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinase-3. J. Biol. Chem. 273, 21736-21743
45. Williamson, R. A., Carr, M. D., Frenkiel, T. A., Feeney, J., and Freedman, R. B. (1997) Mapping the binding site for matrix metalloproteinase on the N-terminal domain of the tissue inhibitor of metalloproteinases-2 by NMR chemical shift perturbation. Biochemistry 36, 13882-13889
46. Evans, E. J., Castro, M. A., O'Brien, R., Kearney, A., Walsh, H., Sparks, L. M., Tucknott, M. G., Davies, E. A., Carmo, A. M., van der Merwe, P. A., Stuart, D. I., Jones, E. Y., Ladbury, J. E., Ikemizu, S., and Davis, S. J. (2006) Crystal structure and binding properties of the CD2 and CD244 (2B4) - binding protein, CD48. J. Biol. Chem. 281, 29309-29320
47. Evans, E. J., Esnouf, R. M., Manso-Sancho, R., Gilbert, R. J., James, J. R., Yu, C., Fennelly, J. A., Vowles, C., Hanke, T., Walse, B., Hünig, T., Sørensen, P., Stuart, D. I., and Davis, S. J. (2005) Crystal structure of a soluble CD28-Fab complex. Nat. Immunol. 6, 271-279
48. Wiseman, T., Williston, S., Brandts, J. F., and Lin, L. N. (1989) Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal. Biochem. 179, 131-137
49. Ladbury, J. E., and Chowdhry, B. Z. (1996) Sensing the heat. The application of isothermal titration calorimetry to thermodynamic studies of biomolecular interactions. Chem. Biol. 3, 791-801
50. Jansson, A., Barnes, E., Klenerman, P., Harlén, M., Sørensen, P., Davis, S. J., and Nilsson, P. (2005) A theoretical framework for quantitative analysis of the molecular basis of costimulation. J. Immunol. 175, 1575-1585
51. Jansson, A., and Davis, S. J. (2011) Quantitative analysis predicts the relative therapeutic efficacy of different forms of CTLA4Ig. Mol. Immunol. 49, 527-536
52. Holm, L., and Park, J. (2000) DaliLite workbench for protein structure comparison. Bioinformatics 16, 566-567
53. Zhang, X., Schwartz, J. C., Guo, X., Bhatia, S., Cao, E., Lorenz, M., Cammer, M., Chen, L., Zhang, Z. Y., Edidin, M. A., Nathenson, S. G., and Almo, S. C. (2004) Structural and functional analysis of the costimulatory receptor programmed death-1. Immunity 20, 337-347
54. Saunders, P. A., Hendrycks, V. R., Lidinsky, W. A., and Woods, M. L. (2005) PD-L2: PD-1 involvement in T cell proliferation, cytokine production, and integrin-mediated adhesion. Eur. J. Immunol. 35, 3561-3569
55. Dong, H., Strome, S. E., Matteson, E. L., Moder, K. G., Flies, D. B., Zhu, G., Tamura, H., Driscoll, C. L., and Chen, L. (2003) Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis. J. Clin. Invest. 111, 363-370
56. Bell, G. I. (1978) Models for the specific adhesion of cells to cells. Science 200, 618-627
57. Prabhu Das, M. R., Zamvil, S. S., Borriello, F., Weiner, H. L., Sharpe, A. H., and Kuchroo, V. K. (1995) Reciprocal expression of co-stimulatory molecules, B7-1 and B7-2, on murine T cells following activation. Eur. J. Immunol. 25, 207-211
58. Sansom, D. M., and Hall, N. D. (1993) B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro. Eur. J. Immunol. 23, 295-298
59. Azuma, M., Yssel, H., Phillips, J. H., Spits, H., and Lanier, L. L. (1993) Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med. 177, 845-850
60. Stamper, C. C., Zhang, Y., Tobin, J. F., Erbe, D. V., Ikemizu, S., Davis, S. J., Stahl, M. L., Seehra, J., Somers, W. S., and Mosyak, L. (2001) Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature 410, 608-611
61. Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S., Thompson, C. B., and Riley, J. L. (2005) CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol. Cell Biol. 25, 9543-9553
62. Schneider, H., Downey, J., Smith, A., Zinselmeyer, B. H., Rush, C., Brewer, J. M., Wei, B., Hogg, N., Garside, P., and Rudd, C. E. (2006) Reversal of the TCR stop signal by CTLA-4. Science 313, 1972-1975
63. Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., Hou, T. Z., Futter, C. E., Anderson, G., Walker, L. S., and Sansom, D. M. (2011) Transendocytosis of CD80 and CD86. A molecular basis for the cell-extrinsic function of CTLA-4. Science 332, 600-603
64. + T lymphocytes. Immunity 20, 327-336
65. Shin, T., Yoshimura, K., Shin, T., Crafton, E. B., Tsuchiya, H., Housseau, F., Koseki, H., Schulick, R. D., Chen, L., and Pardoll, D. M. (2005) In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses. J. Exp. Med. 201, 1531-1541